Delta(9)-THC-induced cognitive deficits in mice are reversed by the GABA(A) antagonist bicuculline.
Stephen A Varvel, E Anum, F Niyuhire, Laura E Wise, Aron H Lichtman
Psychopharmacology March 2005 DOI: 10.1007/s00213-004-1988-2 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Preclinical animal study Peer reviewed |
|---|---|
| Population | Mice, including CB(1) receptor knockout and wild-type strains |
| Interventions | Delta(9)-tetrahydrocannabinol (Delta(9)-THC) bicuculline CGP 36742 muscimol SR 141716 |
| Dose | 10 mg/kg Delta(9)-THC |
| Measures | Morris water maze task, T-maze task |
| Topics | Cannabis |
| Key points | Bicuculline, a GABA(A) antagonist, completely reversed Delta(9)-THC-induced memory deficits in the Morris water maze and T-maze, whereas the GABA(B) antagonist CGP 36742 did not. CB(1) knockout mice were supersensitive to muscimol-induced water maze deficits, but SR 141716-treated wild-type mice responded to muscimol like vehicle-treated controls. The authors argue that GABA(A) receptors may be necessary for Delta(9)-THC-induced memory impairment. |
Abstract
The results of recent in vitro studies have underscored the important role that activation of CB(1) receptors has on GABAergic activity in brain areas associated with memory. The primary purpose of this study was to test the hypothesis that the memory disruptive effects of Delta(9)-tetrahydrocannabinol (Delta(9)-THC) in vivo are mediated through GABAergic systems. Conversely, we also evaluated whether blocking CB(1) receptor signaling would alter memory deficits elicited by GABA agonists. The GABA(A) antagonist bicuculline and GABA(B) antagonist CGP 36742 were evaluated for their ability to ameliorate Delta(9)-THC-induced deficits in a mouse working memory Morris water maze task. Mice were also assessed in a T-maze task, as well as non-cognitive behavioral assays. Additionally, the effects of GABA(A) and GABA(B) agonists were assessed in either CB(1) (-/-) mice or wild type mice treated with the CB(1) antagonist SR 141716. Memory deficits resulting from 10 mg/kg Delta(9)-THC in the Morris water maze were completely reversed by bicuculline, though unaffected by CGP 36742. Bicuculline also blocked the disruptive effects of Delta(9)-THC in the T-maze, but failed to alter non-mnemonic effects of Delta(9)-THC. Although CB(1) (-/-) mice exhibited supersensitivity to muscimol-induced water maze deficits compared with wild type control mice, muscimol elicited virtually identical effects in SR 141716-treated and vehicle-treated wild type mice. This is the first demonstration of which we are aware showing that GABA(A) receptors may play a necessary role in Delta(9)-THC-induced memory impairment in whole animals.
Comparable studies
Other preclinical and animal studies on cannabis, most cited first.
Citations in the library
Cited by 6
- The implications of late-life cannabis use on brain health: A mapping review and implications for future research. Ageing Research Reviews February 25, 2020
- Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids. Philosophical transactions of the Royal Society of London. Series B, Biological sciences December 5, 2012
- Effects of Endocannabinoid System Modulation on Cognitive and Emotional Behavior Frontiers in Behavioral Neuroscience July 22, 2011
- Substitution profile of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Delta9-tetrahydrocannabinol. Psychopharmacology April 2009
- Lack of behavioral sensitization after repeated exposure to THC in mice and comparison to methamphetamine. Psychopharmacology September 2007
and 1 more in the library
Cites 4
- Intracerebral microinjections of delta 9-tetrahydrocannabinol: search for the impairment of spatial memory in the eight-arm radial maze in rats. Brain Research October 18, 2002
- Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proceedings of the National Academy of Sciences of the United States of America July 31, 2001
- Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism. Psychopharmacology July 1996
- Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology June 1995